SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

11 May 2022 07:00

RNS Number : 0217L
TP ICAP Group PLC
11 May 2022
Β 

TP ICAP Group plc ("TP ICAP" or the "Group")

Β 

11 May 2022

Β 

Trading update for the three months ended 31 March 2022

Β 

Highlights

Β· Group revenue, excluding Liquidnet, up 3% in constant currency. Including Liquidnet, Group revenue up 14%; growth across all business divisions;

Β· Varied market conditions: Higher level of volatility and trading activity in January / first half of March; more subdued volumes in February and later in March;

Β· We again increased overall market share during the first quarter;

Β· Better revenue mix: growth across all Global Broking asset classes other than Equities (unchanged);

Β· Global Broking revenue per broker up 8%;

Β· Data & Analytics again delivered double-digit revenue growth;

Β· Good progress on transformation programme: TP Interest Rate Options desk now has #2 market share (from #4), benefiting from Fusion deployment.

Β 

Revenue by division

Β 

Three months to31 March

Β 

Β 

2022

Β£m

2021 as reported Β£m

2021 in constant currency Β£m

Reported change

Constant currency change

Global Broking

317

306

309

Β 

Inter-division revenues1

5

5

5

Β 

Total Global Broking

322

311

314

+4%

+3%

Energy & Commodities

106

100

101

Β 

Inter-division revenues1

1

1

1

Β 

Total Energy & Commodities

107

101

102

+6%

+5%

Excluding Liquidnet

27

27

27

0%

0%

Liquidnet2

62

8

8

+675%

+675%

Total Agency Execution

89

35

35

+154%

+154%

Data & Analytics

40

36

36

+11%

+11%

Post-trade Solutions

4

6

6

-33%

-33%

Total Parameta Solutions

44

42

42

+5%

+5%

Inter-division eliminations1

(6)

(6)

(6)

Β 

Total Revenue

556

483

487

+15%

+14%

Total Revenue (excl. Liquidnet)

494

475

479

+4%

+3%

Β 

1. Inter-division charges have been made by Global Broking and Energy & Commodities to reflect the value of proprietary data provided to the Parameta Solutions division. The Global Broking inter-division revenues and Parameta Solutions inter-division costs are eliminated upon the consolidation of the Group's financial results.

2. In Q1 2021, Β£6m of revenue was included within Agency Execution relating to the post-acquisition period of Liquidnet (the acquisition completed on 23 March 2021); This Liquidnet revenue has been restated to Β£8m by including an additional Β£1m of revenue previously reported in Global Broking, and Β£1m previously reported in COEX Partners (in Agency Execution), reflecting the transfer of desks, which, due to their complementary nature and strategic fit, have been reclassified to be managed and reported as part of Liquidnet.

Β 

Revenue by division (constant currency basis):

Β· Global Broking revenue up 3%, benefitting from increased market volatility. Revenue grew in Rates, Credit, FX & Money Markets and Emerging Markets, but was flat in Equities, resulting in an improved mix.

oΒ  Rates activity increased most notably in short-dated contracts, which have lower transaction values compared with longer-dated contracts;

oΒ  Revenue per broker (productivity) improved by 8%.

Β· Energy & Commodities revenue up 5% driven by growth in Oil and Power & Gas in the US, while in Europe, Power & Gas declined, as high prices and significant volatility led to lower volumes.

Β· Agency Execution revenue of Β£89m increased by 154%. Liquidnet revenue of Β£62m was in line with market activity. Market share increased marginally in the US and was stable in Europe, where we remain a market leader.

Β· Parameta Solutions: Continued double-digit revenue growth in Data & Analytics (+11%).

Β 

Strategic progress

Β· Mark Govoni, former President of US Brokerage at Instinet, joined the Group on 2 May 2022 as the new CEO of Agency Execution, with a primary focus on driving the Liquidnet growth strategy;

Β· Parameta Solutions became an FCA authorised benchmark administrator in May: the first inter-dealer broker that will administer over the counter ('OTC') benchmarks;

Β· Digital Assets Spot Platform: Hudson River Trading added to the list of market makers; custodian network expanded to include BitGo and Komainu.

2022 AGM:

Β· The Group will host its Annual General Meeting today, Wednesday 11 May 2022, at 2.15pm (BST) at the offices of Allen & Overy LLP, One Bishop's Square, London, E1 6AD.

Β 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

Β 

Β 

Enquiries:

Analysts and investors Dominic LaganDirect: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com

Media Richard NewmanDirect: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

Β 

Β 

About TP ICAP

Β· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

Β· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

Β· We operate from more than 60 offices across 27 countries, supporting brokers with award-winning and market-leading technology.

Β 

Further information on the company and its activities is available on the Company's website: www.tpicap.com

Β 

Β 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

11 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBBLLFLELEBBB
Date   Source Headline
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change
13th Dec 20189:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.